InterCure Ltd. (INCR)
NASDAQ: INCR
· Real-Time Price · USD
1.64
-0.02 (-1.20%)
At close: Aug 15, 2025, 3:57 PM
1.61
-1.83%
After-hours: Aug 15, 2025, 07:31 PM EDT
InterCure Income Statement
Financials in ILS. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 56.56M | 56.56M | 62.87M | 62.87M | 73.47M | 73.47M | 102.44M | 106.17M | 105.61M | 100.57M | 95.28M | 87.23M | 79.7M | 61.7M | 45.23M | 33.05M |
Cost of Revenue | 56.36M | 56.36M | 42.04M | 42.04M | 55.31M | 55.31M | 69.8M | 71.85M | 59.63M | 54.36M | 51.65M | 47.84M | 45.34M | 39.64M | 25.28M | 18.29M |
Gross Profit | 195.5K | 195.5K | 20.83M | 20.83M | 18.16M | 18.16M | 32.64M | 34.33M | 25.86M | 46.21M | 43.63M | 39.38M | 34.37M | 22.06M | 19.95M | 14.16M |
Operating Income | -38.86M | -38.86M | 5.26M | 5.26M | -26.67M | -26.67M | 5.82M | 5.95M | -3.47M | 16.18M | 17.93M | 19.99M | 9.05M | 4.54M | 8.88M | 5.72M |
Interest Income | n/a | n/a | n/a | n/a | 8.01M | 8.01M | 719K | 1.53M | 1.74M | 161K | n/a | 1.71M | n/a | n/a | n/a | n/a |
Pretax Income | -44.4M | -44.4M | 737K | 737K | -31.73M | -31.73M | 403K | 1.77M | -8.72M | 11.95M | 21.21M | 19.41M | 2.56M | 2.08M | 8.48M | 5.63M |
Net Income | -34.61M | -34.61M | 716.5K | 716.5K | -33.53M | -33.53M | 4.88M | 214K | 8.55M | 7.26M | 15.64M | 13.37M | -3.07M | -1.64M | 6.19M | 3.21M |
Selling & General & Admin | 31.83M | 31.83M | 23.26M | 23.26M | 23.23M | 23.23M | 25.82M | 26.19M | 23.05M | 30.75M | 24.52M | 18.99M | 21.9M | 15.53M | 11.16M | 8.85M |
Research & Development | 97.5K | 97.5K | 109.5K | 109.5K | 66K | 66K | 99K | 157K | 174K | 120K | 176K | 162K | 220K | 298K | 356K | 361K |
Other Expenses | 7.13M | 7.13M | -7.79M | -7.79M | 21.53M | 21.53M | n/a | 2.03M | 4.2M | n/a | n/a | n/a | 2.93M | n/a | n/a | n/a |
Operating Expenses | 39.06M | 39.06M | 15.57M | 15.57M | 44.83M | 57.01M | 25.92M | 28.38M | 39.16M | 30.87M | 24.7M | 19.15M | 21.54M | 15.83M | 11.52M | 9.21M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 6.14M | 5.71M | 4.19M | 4.4M | 5.52M | 2.29M | n/a | 2.46M | n/a | 90K |
Selling & Marketing Expenses | 13.39M | 13.39M | 13.73M | 13.73M | 12.73M | 12.73M | 14.23M | 13.57M | -20.58M | 16.77M | 14.28M | 9.83M | 8.55M | 6.25M | 4.85M | 3.57M |
Cost & Expenses | 95.42M | 95.42M | 57.61M | 57.61M | 100.14M | 112.32M | 95.72M | 98.19M | 109.08M | 85.23M | 76.35M | 67M | 70.65M | 55.47M | 36.8M | 27.34M |
Income Tax Expense | 8.01M | 8.01M | 740K | 740K | 1.94M | 1.94M | -3.32M | 1.68M | -13.99M | 3.64M | 5.74M | 4.71M | 5.59M | 1.54M | 2.54M | 1.77M |
Shares Outstanding (Basic) | 43.91M | 43.91M | 47.77M | 47.77M | 44.8M | 44.8M | 42.8M | 42.8M | 45.35M | 45.35M | 45.99M | 37.15M | 39.08M | 41.1M | 44.23M | 27.02M |
Shares Outstanding (Diluted) | 43.97M | 43.97M | 47.77M | 47.77M | 44.81M | 44.81M | 42.8M | 42.8M | 45.35M | 45.35M | 45.99M | 37.15M | 42.64M | 41.1M | 51.6M | 27.02M |
EPS (Basic) | -0.79 | -0.79 | 0.01 | 0.01 | -0.75 | -0.75 | 0.11 | 0.00 | 0.12 | 0.16 | 0.34 | 0.36 | -0.08 | -0.04 | 0.14 | 0.03 |
EPS (Diluted) | -0.79 | -0.79 | 0.01 | 0.01 | -0.75 | -0.75 | 0.11 | 0.00 | 0.12 | 0.16 | 0.34 | 0.36 | -0.07 | -0.04 | 0.12 | 0.02 |
EBITDA | -46.68M | -47.05M | 7.2M | 7.2M | -4.59M | -4.77M | 9.01M | 10.66M | -181K | 18.96M | 26.73M | 24.05M | 6.78M | 6.22M | 9.68M | 6.96M |
EBIT | -49.1M | -49.1M | 5.16M | 5.16M | -6.64M | -6.64M | 6.54M | 7.48M | -4.53M | 16.34M | 26.73M | 21.7M | 3.58M | 4.54M | 8.43M | 5.72M |
Depreciation & Amortization | 2.42M | 2.05M | 2.05M | 2.05M | 2.05M | 1.87M | 3.18M | 3.18M | 4.35M | 2.72M | 2.27M | 2.35M | 931K | 1.68M | 1.25M | 1.25M |